Latest stories on VERA
Vera Therapeutics price target raised to $83 from $76 at JPMorgan
The Fly67 · bullishanalyst
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Vera Therapeutics to Participate at Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Vera Therapeutics to Participate at Upcoming Investor Conferences
StockTitan55 · neutralgeneral
3 Best Stocks With 100%+ Upside to Buy This Week, According to Analysts
TipRanks57 · neutralanalyst
Vera Therapeutics: FDA's eGFR Analysis Supports A Speculative Buy
Seeking Alpha58 · neutralanalyst
Vera rises after FDA review for kidney disease therapy
Seeking Alpha67 · bullishproduct/pr
Goldman Sachs lowers Vera Therapeutics stock price target to $80
Investing.com Analyst Ratings34 · bearishanalyst
Vera Therapeutics price target raised to $84 from $78 at Raymond James
The Fly63 · neutralanalyst
Vera Therapeutics Price Target Lowered To 34 From 43 At Wedbush
The Fly34 · bearishanalyst
Vera Therapeutics Price Target Lowered To 66 From 70 At Bofa
The Fly38 · neutralanalyst
Vera Therapeutics Reports Q3 Eps 1 52 Consensus 1 59
The Fly34 · bearishearnings
Vera Therapeutics GAAP EPS of -$1.52 beats by $0.04
Seeking Alpha56 · neutralearnings
Vera Therapeutics, Inc. (VERA) files 8-K
SEC 8-K50 · neutralgeneral
Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
StockTitan63 · neutralearnings
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | VERA Stock News
StockTitan50 · neutralgeneral
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Barchart50 · neutralgeneral
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Vera Therapeutics: A Crowded IgAN Market Leaves No Room For A Premium (Downgrade)
Seeking Alpha32 · bearishanalyst
Vera Therapeutics Welcomes Nancy Boman as Chief Regulatory Officer: Bringing New Depth to Regulatory Leadership
July 9, 2026
MarketChameleon63 · neutralproduct/pr
Vera Therapeutics Announces New Chief Regulatory Officer
TipRanks55 · neutralgeneral